MX2017005783A - Nutritional compositions containing a prebiotic and lactoferrin and uses thereof. - Google Patents

Nutritional compositions containing a prebiotic and lactoferrin and uses thereof.

Info

Publication number
MX2017005783A
MX2017005783A MX2017005783A MX2017005783A MX2017005783A MX 2017005783 A MX2017005783 A MX 2017005783A MX 2017005783 A MX2017005783 A MX 2017005783A MX 2017005783 A MX2017005783 A MX 2017005783A MX 2017005783 A MX2017005783 A MX 2017005783A
Authority
MX
Mexico
Prior art keywords
lactoferrin
prebiotic
composition including
pediatric subject
compositions containing
Prior art date
Application number
MX2017005783A
Other languages
Spanish (es)
Inventor
Jouni Zeina
Wittke Anja
Berg Brian
Chichlowski Maciej
Waworuntu Rosaline
Original Assignee
Mjn Us Holdings Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US14/535,717 external-priority patent/US20150119322A1/en
Priority claimed from US14/636,810 external-priority patent/US10709770B2/en
Application filed by Mjn Us Holdings Llc filed Critical Mjn Us Holdings Llc
Publication of MX2017005783A publication Critical patent/MX2017005783A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Pediatric Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Provided is a composition and method for modulating serotonergic receptor expression, reducing anxiety-like behavior and stress-induced inflammatory response in a pediatric subject, the method including administering to the pediatric subject a nutritional composition including lactoferrin from a non-human source and a prebiotic composition including polydextrose and/or galactooligosaccharides. Further provided is a method for reducing constipation in a pediatric subject by providing a nutritional composition including lactoferrin from a non-human source and a prebiotic composition including polydextrose and/or galactooligosaccharides.
MX2017005783A 2014-11-07 2015-10-08 Nutritional compositions containing a prebiotic and lactoferrin and uses thereof. MX2017005783A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14/535,717 US20150119322A1 (en) 2013-07-31 2014-11-07 Nutritional compositions containing a prebiotic and lactoferrin and uses thereof
US14/636,810 US10709770B2 (en) 2013-07-31 2015-03-03 Nutritional compositions containing a prebiotic and lactoferrin and uses thereof
PCT/US2015/054628 WO2016073132A1 (en) 2014-11-07 2015-10-08 Nutritional compositions containing a prebiotic and lactoferrin and uses thereof

Publications (1)

Publication Number Publication Date
MX2017005783A true MX2017005783A (en) 2017-07-28

Family

ID=54347872

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017005783A MX2017005783A (en) 2014-11-07 2015-10-08 Nutritional compositions containing a prebiotic and lactoferrin and uses thereof.

Country Status (10)

Country Link
EP (1) EP3214951A1 (en)
CN (1) CN107072282A (en)
AU (1) AU2015343613A1 (en)
BR (1) BR112017008747A2 (en)
CA (1) CA2962136A1 (en)
MX (1) MX2017005783A (en)
PH (1) PH12017500763A1 (en)
SG (1) SG11201702036QA (en)
TW (1) TW201630617A (en)
WO (1) WO2016073132A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112020018319A2 (en) * 2018-03-09 2020-12-29 Frimline Private Limited PHARMACEUTICAL COMPOSITION FOR ANEMIA
CN110496227B (en) * 2019-10-10 2022-06-14 河南科技学院 Oat beta-glucan-based clear hydrophobic polyphenol delivery system and preparation method thereof
MX2022013442A (en) * 2020-04-27 2022-11-30 Nestle Sa Method for producing milk like products.
GB202200069D0 (en) * 2022-01-05 2022-02-16 Vemico Ltd Compositions and methods for immunomodulation via control of intestinal microbiome

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE61701B1 (en) 1986-07-17 1994-11-30 Morinaga Milk Industry Co Ltd Process for producing bovine lactoferrin in high purity
US5407957A (en) 1990-02-13 1995-04-18 Martek Corporation Production of docosahexaenoic acid by dinoflagellates
DK165090D0 (en) 1990-07-09 1990-07-09 Kem En Tec As CONLOMERATED PARTICLES
ZA92452B (en) 1991-01-24 1992-10-28 Martek Corp Microbial oil mixtures and uses thereof
US5374567A (en) 1993-05-20 1994-12-20 The United States Of America As Represented By The Secretary Of The Navy Operational amplifier using bipolar junction transistors in silicon-on-sapphire
DE69524386D1 (en) 1994-02-16 2002-01-17 Pharming Intellectual Pty Bv ISOLATION OF LACTOFERRIN FROM MILK
SE9503926D0 (en) 1995-11-07 1995-11-07 Pharmacia Biotech Ab Adsorption process and separation medium
DE69939590D1 (en) 1998-06-18 2008-10-30 Upfront Chromatography As Kope EXPANDED BED ABSORPTION SYSTEM
AU2001258238B2 (en) 2000-05-12 2005-06-23 Upfront Chromatography A/S A bed adsorption system
US6332533B1 (en) 2000-08-29 2001-12-25 H.H.H. Incorprorated Media holder mouse pad
EP1552752B1 (en) 2001-06-01 2011-07-13 Upfront Chromatography A/S Fractionation of protein containing mixtures
DK1480524T3 (en) 2002-03-07 2013-07-15 Upfront Chromatography As Method for isolating lactoferrin
EP2251030A1 (en) * 2009-05-12 2010-11-17 Nestec S.A. Lactoferrin and brain health and development in infants
KR101143997B1 (en) * 2010-03-04 2012-05-09 한미사이언스 주식회사 Complex formulation for oral administration comprising probiotic formulation and 5-ht4 receptor agonist and method for the preparation thereof
US8968722B2 (en) * 2010-12-29 2015-03-03 Mead Johnson Nutrition Company Milk-based nutritional compositions containing lactoferrin and uses thereof
US9661874B2 (en) * 2013-03-11 2017-05-30 Mead Johnson Nutrition Company Nutritional compositions containing structured fat globules and uses thereof

Also Published As

Publication number Publication date
AU2015343613A1 (en) 2017-04-06
EP3214951A1 (en) 2017-09-13
CN107072282A (en) 2017-08-18
SG11201702036QA (en) 2017-04-27
CA2962136A1 (en) 2016-05-12
PH12017500763A1 (en) 2017-10-09
TW201630617A (en) 2016-09-01
BR112017008747A2 (en) 2017-12-19
WO2016073132A1 (en) 2016-05-12

Similar Documents

Publication Publication Date Title
HK1251901A1 (en) Alkenyl substituted 2,5-piperazinediones and their use in compositions for delivering an agent to a subject or cell
MX2017005260A (en) Activated bifidobacteria and methods of use thereof.
MX2015009552A (en) Compositions that include hydrophobizing agents and stabilizers and methods for making and using same.
MX2016011110A (en) Anti-foam compositions.
JO3343B1 (en) Novel5-aminotetrahydroquinoline-2-carboxylic acids and their use
MX2017009720A (en) Oligosaccharide compositions for use in nutritional compositions, and methods of producing thereof.
PH12017500763A1 (en) Nutritional compositions containing a prebiotic and lactoferrin and uses thereof
MX2020004419A (en) Modified meningococcal fhbp polypeptides.
PH12017500836A1 (en) Transdermal formulations
MX2016007278A (en) Methods and pharmaceutical compositions for expressing a polynucleotide of interest in the retinal pigment epithelium of a subject.
PH12015501334B1 (en) Milk-based nutritional compositions containing lactoferrin and uses thereof
MX2019010594A (en) Beta-casein a2 and prevention of inflammation of the bowel.
MX2017000827A (en) Sugar compositions for tableting by direct compression.
MX2017006701A (en) Infant formula with rrr-alpha-tocopherol, 2'-fucosyllactose, and a probiotic.
SG10201806854XA (en) Compositions comprising 15-ohepa and methods of using the same
SG10201707565WA (en) Oligosaccharide compositions, glycoproteins and methods to produce the same in prokaryotes
MX2021006458A (en) Yeast cell wall enriched in mannan oligosaccharide protein.
MX2017000829A (en) Sugar compositions for tableting by direct compression.
AR100028A1 (en) NUTRITIONAL COMPOSITIONS CONTAINING ESTEARIDÓNIC ACID
WO2015027160A3 (en) Allosteric modulators of the cannibinoid 1 receptor
MX2016008821A (en) Aerated strained fermented dairy compositions.
MX2015016603A (en) Corticosteroid compositions.
MY188694A (en) Anticariogenic agent and anticariogenic composition
MX368972B (en) Sialylated glycoprotein compositions and uses thereof.
AR102546A1 (en) NUTRITIONAL COMPOSITIONS CONTAINING A PREBIOTIC AND LACTOFERRINE AND METHOD FOR THE MODULATION OF EXPRESSION OF SEROTONERERGIC RECEIVER